Source: BioPortfolio

Numerate: Numerate Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 13032018 Prices from USD $250

SummaryNumerate Inc Numerate is a drug discovery company. The company provides design of modulators of the ryanodine receptor 2 for the treatment of heart failure and atrial fibrillation. It designs agonists of the longchain free fatty acid receptors FFA1 ...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Guido Lanza's photo - President & CEO of Numerate

President & CEO

Guido Lanza

CEO Approval Rating

77/100

Read more